Autoimmune Diseases
Feature
NIH to study COVID vaccine booster in people with autoimmune disease
The trial will look at the impact of a booster in patients with five different autoimmune diseases who are either on or off immunosuppressives.
Conference Coverage
Hep B vaccine response varied among youth with inflammatory, autoimmune disorders
While the vaccine series provides protection in healthy individuals more than 95% of the time, a decreased response has been noted in specific...
From the Journals
CAR T-cell therapy drives refractory SLE into remission
B-cell depletion with chimeric antigen receptor T cells induced both serologic and clinical remissions in a patient with treatment-resistant lupus...
News from the FDA/CDC
FDA approves anifrolumab (Saphnelo) as first new lupus treatment in more than 10 years
Anifrolumab, a monoclonal antibody against type 1 interferon receptor, improved overall disease activity in patients with SLE on standard therapy...
From the Journals
COVID-19 vaccination does not increase risk of flare in patients with lupus
An international web-based survey found a very low rate of medically confirmed flare post COVID vaccination in nearly 700 participants.
Conference Coverage
Autoinflammatory diseases ‘not so rare after all,’ expert says
“Dermatologists are in a unique position because they will often be the first specialist to see these patients and therefore make the diagnosis...
News from the FDA/CDC
FDA approves intravenous immunoglobulin for dermatomyositis
Octagam 10% is the first treatment to have an indication specifically for dermatomyositis.
From the Journals
Neuropsychiatric event etiology in lupus helps define predictors, outcomes
Male sex, active SLE, and corticosteroid use were among the factors positively associated with neuropsychiatric events in patients with SLE.
From the Journals
Lupus images fall short on diverse examples
A review of textbooks, medical journals, and online sources shows an underrepresentation of skin of color patients.
Conference Coverage
New biomarkers may predict interstitial lung disease progression in patients with systemic sclerosis
Radiographic assessment of interstitial lung disease progression and proteins from bronchoalveolar lavage may independently provide better insight...
Case Reports
Nivolumab-Induced Granuloma Annulare
Immune-related adverse events (irAEs) frequently occur in patients on immunotherapy, with the skin representing the most common site of...